FUBT
PYXS icon

First United Bank & Trust’s Pyxis Oncology PYXS Stock Holding History

First United Bank & Trust’s Portfolio PYXS Stock Details PYXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.38K Buy
+2,500
New +$4.78K ﹤0.01% 348

Other funds holding PYXS

HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
HIMS
Hager Investment Management Services New London, New Hampshire $217M AUM 56.89% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
PWA
Physician Wealth Advisors Midvale, Utah $837M AUM 26% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

First United Bank & Trust's PYXS Position: Q2 2026 in Review

First United Bank & Trust opened a new position in Pyxis Oncology (PYXS) in Q2 2026: 2,500 shares worth $7.38K. The stake represents ﹤0.01% of the portfolio and ranks #348 among its holdings.

7 funds tracked by Wall St. Rank hold PYXS as of Q2 2026.

  • First United Bank & Trust held 2,500 shares of Pyxis Oncology worth $7.38K as of Q2 2026.
  • Pyxis Oncology was a new First United Bank & Trust position in Q2 2026.
  • Pyxis Oncology made up ﹤0.01% of First United Bank & Trust's portfolio in Q2 2026, its #348 holding.
  • 7 funds tracked by Wall St. Rank held Pyxis Oncology as of Q2 2026.

Based on First United Bank & Trust's 13F filing for Q2 2026, filed 20 Jul 2026.